WebDisclosure WebDisclosure
Basculer en Français
10370 Companies
216107 Keywords
145830 Articles
114435 Press releases
Headlines Articles Press releases Indivumed GmbH Remove
  1. Home
  2. Companies
  3. Indivumed GmbH
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 12/10/2025 at 14:10, 4 months 29 days ago

    Indivumed and University of Rochester expand cancer research collaboration

    Precision Oncology Cancer Research Novel Therapeutics Patient-derived Models Clinical Collaboration
  • BRIEF

    published on 12/10/2025 at 14:10, 4 months 29 days ago

    Indivumed et l'Université de Rochester étendent leur collaboration en matière de recherche sur le cancer

    Oncologie De Précision Nouvelles Thérapies Recherche Sur Le Cancer Modèles Dérivés De Patients Collaboration Clinique
  • PRESS RELEASE

    published on 12/10/2025 at 14:05, 4 months 29 days ago

    Indivumed and University of Rochester Medical Center expand collaboration for patient-centric discovery of novel therapeutics

    Indivumed partners with University of Rochester Medical Center for patient-centric cancer therapeutics discovery, focusing on precision oncology and advanced stages of solid cancers
    Precision Oncology Cancer Research Indivumed University Of Rochester Therapeutics Discovery
    Logo of Indivumed GmbH
Accesswire
  • Published on 05/08/2026 at 15:55, 19 minutes ago

    Class 1 Nickel and Technologies Ltd. Announces Private Placement and Share for Debt Offering

  • Published on 05/08/2026 at 15:00, 1 hour 14 minutes ago

    Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule

  • Published on 05/08/2026 at 14:55, 1 hour 19 minutes ago

    Nepra Foods Inc. to Present at the 16th Annual LD Micro Invitational

  • Published on 05/08/2026 at 14:30, 1 hour 44 minutes ago

    Unusual Machines Hosts Live Drone Ecosystem Demonstrations at XPONENTIAL 2026

  • Published on 05/08/2026 at 14:00, 2 hours 14 minutes ago

    BlackBerry Announces Renewal of Normal Course Issuer Bid Share Buyback Program

View all ACCESSWIRE
EQS Group
  • Published on 05/08/2026 at 16:05, 9 minutes ago

    ANTHBOT Announces Marc ter Stegen as Global Brand Ambassador

  • Published on 05/08/2026 at 15:32, 41 minutes ago

    EQS-Adhoc: The Management Board and Supervisory Board of 11880 Solutions AG approve a proposal for a 5:1 share capital reduction

  • Published on 05/08/2026 at 15:26, 48 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc

  • Published on 05/08/2026 at 15:25, 48 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Schroders plc

  • Published on 05/08/2026 at 15:24, 50 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: JTC plc

View all EQS
Les Echos
  • Published on 05/07/2026 at 19:15, 20 hours 59 minutes ago

    2026 Annual General Meeting: approval of all resolutions submitted to the Meeting

  • Published on 05/07/2026 at 19:15, 20 hours 59 minutes ago

    Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote

  • Published on 05/07/2026 at 19:06, 21 hours 8 minutes ago

    Disclosure of Share Capital and Voting Rights as of April 30, 2026

  • Published on 05/07/2026 at 19:06, 21 hours 8 minutes ago

    Déclaration du nombre d’actions et droits de vote au 30 avril 2026

  • Published on 05/07/2026 at 19:00, 21 hours 14 minutes ago

    ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy